Subscribe To
Nokia (nok) brings ai-driven upgrade in fixed network saas suite
Nokia (NOK) unveils new AI-driven upgrades in its Fixed Network SaaS Suite to support service providers with enhanced customer service capabilities an...
May 22, 2023, 12:50 pm
Why azul stock is up today
Azul's stock got an upgrade on Monday, with the analyst arguing headwinds are receding for the airline....
May 22, 2023, 12:37 pm
Fortinet, a cybersecurity and ai leader, breaks out; analysts bullish on outlook
Growth stock Fortinet broke out after strong earnings. Analysts upgraded the AI play in cybersecurity on strong execution The post Fortinet, A Cyberse...
May 22, 2023, 12:20 pm
Plywood market is expected to reach usd 152,527.58 billion by 2030, with a cagr of 6.10% – report by market research future (mrfr)
Plywood Market Research Report Information, By grade (MR Grade, BWR Grade, Fire Resistant Grade, BWP Gr...
May 22, 2023, 12:15 pm
Bear notes puts minor dent on outperforming apple stock
Apple Inc (NASDAQ:AAPL) stock is taking a breather after last session's one-year high of $176.39, after a down...
May 22, 2023, 11:39 am
Draftkings stock has doubled in 2023. one analyst sees more upside.
UBS analyst Robin Farley upgraded sports-betting firm DraftKings to Buy from Neutral, and lifted her price target to $30 from $19....
May 22, 2023, 10:59 am
All aboard! the sell-side has railroads in reversal
Growing trends within the railroad market have the stocks in reversal. The combination of institutional support and analysts' upgrades have the stocks...
May 22, 2023, 10:55 am
Factbox: ford strikes multiple lithium deals to ramp up ev production
U.S. automaker Ford Motor Co on Monday entered into a series of new deals to source battery-grade lithi...
May 22, 2023, 9:40 am
Apple's stock downgraded as analyst warns that revenue could disappoint
Apple Inc.'s iPhone business normally heats up in the fall when the company announces its new smartphone models, but one analyst sees a rocky road bet...
May 22, 2023, 9:35 am
Analyst: gamble on draftkings stock now
The shares of DraftKings Inc (NASDAQ:DKNG) are 3.8% higher to trade at $25.02 this morning, after UBS upgraded the sports gambling company to "buy" f...
May 22, 2023, 9:33 am
Tesla sell signals confirmed (technical analysis, downgrade)
This is a technical analysis article. In our previous article, we identified Tesla as a stock with Sell Signals. Those signals have not changed, despi...
May 22, 2023, 9:27 am
Helium one receives hefty resource upgrade at tai prospect
Helium One Global said it had received independent verification of the prospective resources at the Tai prospect in Tanzania, with a new competent per...
May 22, 2023, 3:42 am
Sofi: false sense of risk creates an exceptional opportunity (rating upgrade)
The recent sell-off concerning SoFi's outstanding loan balance is unwarranted. Deposit inflows, customer income, and customer credit scores are all ex...
May 22, 2023, 2:15 am
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:00 pm
Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:00 pm
Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:00 pm